NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Reports Q2 Results as Strategic Pivot Advances

CNS Pharmaceuticals (NASDAQ: CNSP), a biotechnology company focused on building a pipeline of innovative therapies addressing significant unmet medical needs, reported second-quarter 2026 results and provided an update on the corporate strategy introduced in March. Cash and cash equivalents totaled approximately $20 million at June 30, up from $7.2 million at Dec. 31, 2025, primarily […]